BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12913923)

  • 21. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors.
    Nielen MM; van Schaardenburg D; Reesink HW; van de Stadt RJ; van der Horst-Bruinsma IE; de Koning MH; Habibuw MR; Vandenbroucke JP; Dijkmans BA
    Arthritis Rheum; 2004 Feb; 50(2):380-6. PubMed ID: 14872479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum autoantibodies that bind citrullinated fibrinogen are frequently found in patients with rheumatoid arthritis.
    Hill JA; Al-Bishri J; Gladman DD; Cairns E; Bell DA
    J Rheumatol; 2006 Nov; 33(11):2115-9. PubMed ID: 16924693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies.
    Tamai M; Kawakami A; Uetani M; Takao S; Arima K; Iwamoto N; Fujikawa K; Aramaki T; Kawashiri SY; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Aoyagi K; Eguchi K
    Arthritis Rheum; 2009 Jun; 61(6):772-8. PubMed ID: 19479686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project).
    Kastbom A; Strandberg G; Lindroos A; Skogh T
    Ann Rheum Dis; 2004 Sep; 63(9):1085-9. PubMed ID: 15308517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
    Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM
    Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis.
    Solanki K; Spellerberg M; Chapman P; Moller P; O'Donnell J
    N Z Med J; 2004 Oct; 117(1203):U1097. PubMed ID: 15477921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic performances of anti-cyclic citrullinated peptide antibodies type IgM, IgA and IgG in Syrian patients with rheumatoid arthritis.
    Awwad HM; Aboukhamis I
    Clin Lab; 2010; 56(3-4):95-102. PubMed ID: 20476640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of anti cyclic citrullinated peptide antibodies in erosive disease in patients with rheumatoid arthritis.
    Shankar S; Grover R; Handa R
    Indian J Med Res; 2006 Dec; 124(6):689-96. PubMed ID: 17287557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement.
    Alessandri C; Bombardieri M; Papa N; Cinquini M; Magrini L; Tincani A; Valesini G
    Ann Rheum Dis; 2004 Oct; 63(10):1218-21. PubMed ID: 15361374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibodies to cyclic citrullinized peptide in rheumatoid arthritis].
    Aleksandrova EN; Chemeris NA; Karateev DE; Novikov AA; Brodetskaia KA; Nasonov EL
    Ter Arkh; 2004; 76(12):64-8. PubMed ID: 15724930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies to cyclic citrullinated peptides in psoriatic arthritis.
    Bogliolo L; Alpini C; Caporali R; Scirè CA; Moratti R; Montecucco C
    J Rheumatol; 2005 Mar; 32(3):511-5. PubMed ID: 15742445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis.
    Sihvonen S; Korpela M; Mustila A; Mustonen J
    J Rheumatol; 2005 Nov; 32(11):2089-94. PubMed ID: 16265684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
    J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.
    de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Verpoort KN; Schreuder GM; Ewals JA; Terwiel JP; Ronday HK; Kerstens PJ; Toes RE; de Vries RR; Breedveld FC; Dijkmans BA; Huizinga TW; Allaart CF
    Arthritis Rheum; 2008 May; 58(5):1293-8. PubMed ID: 18438829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations.
    Korkmaz C; Us T; Kaşifoğlu T; Akgün Y
    Clin Biochem; 2006 Oct; 39(10):961-5. PubMed ID: 16979149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis.
    Candia L; Marquez J; Gonzalez C; Santos AM; Londoño J; Valle R; Zabaleta J; Yaqub Z; Espinoza LR
    J Clin Rheumatol; 2006 Oct; 12(5):226-9. PubMed ID: 17023808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody.
    Mikuls TR; O'Dell JR; Stoner JA; Parrish LA; Arend WP; Norris JM; Holers VM
    Arthritis Rheum; 2004 Dec; 50(12):3776-82. PubMed ID: 15593224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
    De Rycke L; Verhelst X; Kruithof E; Van den Bosch F; Hoffman IE; Veys EM; De Keyser F
    Ann Rheum Dis; 2005 Feb; 64(2):299-302. PubMed ID: 15166003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibodies in early rheumatoid arthritis: Brasília cohort: results of a three-year serial analysis.
    da Mota LM; Santos Neto LL; Pereira IA; Burlingame R; Ménard HA; Laurindo IM
    Rev Bras Reumatol; 2011 Dec; 51(6):564-71. PubMed ID: 22124591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.